Aeovian Pharmaceuticals Funding: $105M Raised, Series B
Aeovian Pharmaceuticals is a Biotech company based in Berkeley, California. It has raised $105M in total funding. Latest round: Series B.
Aeovian Pharmaceuticals funding overview
Aeovian Pharmaceuticals is a Biotech company based in Berkeley, California. Aeovian Pharmaceuticals has raised $105M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2025. The round record for Aeovian Pharmaceuticals runs through 2025; nothing later has been disclosed. Investors on record include Luma Group, Hevolution. 2 distinct backers are named across the disclosed rounds.
Aeovian Pharmaceuticals at a glance
Total raised
$105M
Latest round
Series B
Latest round date
January 2025
Industry
Biotech
Headquarters
Berkeley, California
Notable investors
Luma Group, Hevolution
Frequently asked about Aeovian Pharmaceuticals funding
How much has Aeovian Pharmaceuticals raised?
Aeovian Pharmaceuticals has raised $105M in total disclosed funding across the rounds on record.
Who has invested in Aeovian Pharmaceuticals?
Luma Group, Hevolution are named among the investors backing Aeovian Pharmaceuticals.
What was the latest Aeovian Pharmaceuticals funding round?
The most recent disclosed round is a Series B, announced in January 2025.
Where is Aeovian Pharmaceuticals based?
Aeovian Pharmaceuticals is based in Berkeley, California.
What sector does Aeovian Pharmaceuticals operate in?
Aeovian Pharmaceuticals is tracked under Biotech from Berkeley, California, with $105M in disclosed funding.
When did Aeovian Pharmaceuticals last raise?
The last disclosed Aeovian Pharmaceuticals round closed in January 2025 at Series B.
Every Aeovian Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Berkeley at a similar stage.
